Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Elevated plasma concentrations of lipoprotein(a) in patients with end-stage renal disease are not related to the size polymorphism of apolipoprotein(a).

The Journal of clinical investigation - 1 Feb 1993

Dieplinger H, Lackner C, Kronenberg F, Sandholzer C, Lhotta K, Hoppichler F, Graf H, König P

Abstract excerpt

Patients with terminal renal insufficiency suffer from an increased incidence of atherosclerotic diseases. Elevated plasma concentrations of lipoprotein(a) [Lp(a)] have been established as a genetically controlled risk factor for these diseases. Variable alleles at the apo(a) gene locus determine to a large extent the Lp(a) concentration in the general population. In addition, other genetic and nongenetic factors...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Apolipoproteins

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Apolipoproteins B

Share to Arteriosclerosis

Share to Cholesterol

Share to Lipoprotein(a)

Share to Phenotype

Share to Polymorphism, Genetic

Source

Open in PubMed Open full text

Identifiers

PMID: 8432847
DOI: 10.1172/JCI116213
PMCID: PMC287937

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Elevated plasma concentrations of lipoprotein(a) in patients with end-stage renal disease are not related to the size polymorphism of apolipoprotein(a).PMID 8432847Read ↗

Apolipoprotein(a) phenotypes and lipoprotein(a) concentrations in patients with renal failure.Semantic proximity Read ↗

Apolipoprotein(a) phenotype-associated decrease in lipoprotein(a) plasma concentrations after renal transplantation.Semantic proximity Read ↗

Apolipoprotein(a) phenotypes predict the risk for carotid atherosclerosis in patients with end-stage renal disease.Semantic proximity Read ↗

The apolipoprotein(a) size polymorphism is associated with nephrotic syndrome.Semantic proximity Read ↗

Lipoprotein(a) serum levels and apolipoprotein(a) phenotypes in children with chronic renal disease.Semantic proximity Read ↗

Multicenter study of lipoprotein(a) and apolipoprotein(a) phenotypes in patients with end-stage renal disease treated by hemodialysis or continuous ambulatory peritoneal dialysis.Semantic proximity Read ↗

Lipoprotein(a) and apolipoprotein(a) isoforms and proteinuria in patients with moderate renal failure.Semantic proximity Read ↗

Renovascular arteriovenous differences in Lp[a] plasma concentrations suggest removal of Lp[a] from the renal circulation.Semantic proximity Read ↗

Lipoprotein(a)Semantic proximity Read ↗

Genetics and metabolism of lipoprotein(a) and their clinical implications (Part 1).Semantic proximity Read ↗

Lipoprotein(a) in health and disease.Semantic proximity Read ↗

Pentanucleotide repeat and size polymorphisms in the apolipoprotein(a) gene are associated with the lipoprotein(a) concentration in chronic hemodialysis patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.